Published in Cancer Res on November 15, 2000
Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell (2008) 4.20
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood (2005) 2.03
A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res (2006) 2.02
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood (2011) 1.91
Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet (2012) 1.82
Nuclear pore proteins and cancer. Semin Cell Dev Biol (2009) 1.44
Therapeutic targeting of MLL. Blood (2009) 1.36
Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics (2006) 1.32
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer (2009) 1.11
LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer (2007) 1.10
The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering. Nucleic Acids Res (2010) 1.08
High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region. Nucleic Acids Res (2010) 1.08
Fusion of the NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid leukemia translocation. BMC Genet (2001) 1.07
Virological and cellular roles of the transcriptional coactivator LEDGF/p75. Curr Top Microbiol Immunol (2009) 1.07
Alternative splicing and caspase-mediated cleavage generate antagonistic variants of the stress oncoprotein LEDGF/p75. Mol Cancer Res (2008) 1.04
The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity. Mol Cancer Res (2012) 0.90
Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types. PLoS One (2012) 0.88
Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes. Mar Drugs (2010) 0.87
Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene. PLoS Pathog (2014) 0.84
The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med (2015) 0.83
Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype. PLoS One (2016) 0.76
Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature (1999) 5.77
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
ABFs, a family of ABA-responsive element binding factors. J Biol Chem (2000) 4.98
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res (2001) 3.30
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med (1991) 3.05
SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat Immunol (2000) 2.87
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol (2001) 2.80
The drug resistance-related protein LRP is the human major vault protein. Nat Med (1995) 2.78
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood (2001) 2.53
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study. Blood (2001) 2.52
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol (1994) 2.50
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood (2001) 2.50
Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med (1997) 2.24
Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23
Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science (1993) 2.17
Wisconsin Card Sorting Test performance in patients with focal frontal and posterior brain damage: effects of lesion location and test structure on separable cognitive processes. Neuropsychologia (2000) 2.03
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res (1993) 1.99
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood (1999) 1.90
Life course impacts of parenting a child with a disability. Am J Ment Retard (2001) 1.87
Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood (1997) 1.75
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med (2001) 1.72
Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant (2000) 1.64
The role of CALM-AF10 gene fusion in acute leukemia. Leukemia (2007) 1.63
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J Int Neuropsychol Soc (2000) 1.58
Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood (1996) 1.57
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy (2006) 1.57
HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function. Am J Kidney Dis (1990) 1.52
DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol (1997) 1.51
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia (2008) 1.49
Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia (2005) 1.49
Parathyroid hormone-related protein maintains mammary epithelial fate and triggers nipple skin differentiation during embryonic breast development. Development (2001) 1.48
Human T lymphocyte genetic modification with naked DNA. Mol Ther (2000) 1.47
NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res (1998) 1.42
The effect of horse simulator riding on visual analogue scale, body composition and trunk strength in the patients with chronic low back pain. Int J Clin Pract (2014) 1.39
Modulation of adenovirus-mediated gene transfer by nitric oxide. Am J Respir Cell Mol Biol (1997) 1.38
Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol (1999) 1.38
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.33
The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med (1992) 1.32
Asymmetric total synthesis of ent-(-)-roseophilin: assignment of absolute configuration. J Am Chem Soc (2001) 1.32
Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. Proc Natl Acad Sci U S A (1991) 1.32
Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer (1989) 1.30
Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun (1992) 1.28
A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J Biol Chem (1997) 1.26
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia (1999) 1.26
Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation (1984) 1.23
Partial deletion of chromosome 6p: delineation of the syndrome. Am J Med Genet (1991) 1.22
A capacitative calcium current in cultured skeletal muscle cells is mediated by the calcium-specific leak channel and inhibited by dihydropyridine compounds. J Biol Chem (1996) 1.22
Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab (2011) 1.20
A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood (2000) 1.20
Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood (1999) 1.18
Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy. Cytotherapy (2003) 1.18
Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assays. J Clin Microbiol (1990) 1.16
Cytotoxic polyacetylenes from the marine sponge Petrosia sp. J Nat Prod (1999) 1.16
Expression of the SIL gene is correlated with growth induction and cellular proliferation. Cell Growth Differ (1997) 1.14
Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. Oncogene (2012) 1.14
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood (1987) 1.14
Acute murine cytomegalovirus infection induces lethal hepatitis. J Infect Dis (1993) 1.13
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant (2001) 1.13
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer (2000) 1.12
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. J Clin Oncol (1998) 1.12
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia. Genes Chromosomes Cancer (2001) 1.12
Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells. Leukemia (2006) 1.12
Acetic acid formation in Escherichia coli fermentation. Biotechnol Bioeng (1992) 1.11
Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis (1999) 1.11
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood (1998) 1.11
Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med (1980) 1.10
The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A (2000) 1.08
Properties and characterization of binding protein dependent active transport of glutamine in isolated membrane vesicles of Escherichia coli. Biochemistry (1983) 1.08
The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life. Cancer Nurs (1992) 1.08
MAGOH interacts with a novel RNA-binding protein. Genomics (2000) 1.08
High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia (2003) 1.07
Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood (1991) 1.07
HIV-associated parotid lymphoepithelial cysts. J Am Dent Assoc (1999) 1.07
The reconstitution of binding protein-dependent active transport of glutamine in isolated membrane vesicles from Escherichia coli. J Biol Chem (1981) 1.06
Estimation of kinetics of mercury detoxification from low-inoculum batch cultures of Pseudomonas aeruginosa PU21 (Rip64). J Biotechnol (1995) 1.06
Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation (1988) 1.05
Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol (1999) 1.05
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood (2001) 1.05
Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J Infect Dis (1997) 1.05
Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum Gene Ther (1999) 1.04
Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis (1986) 1.03
Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens (2004) 1.03
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant (2003) 1.03
The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg (1987) 1.02
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood (1998) 1.02
The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood (1999) 1.02
Juvenile fibroadenoma in 13-month-old female child. J Paediatr Child Health (2005) 1.02